Evidence map›Paper›PMID 30643259›Full record

ArticleNature immunology2019

The Ca

Sonal Srikanth, Jin Seok Woo, Beibei Wu, Yasser M El-Sherbiny, Jennifer Leung, Koollawat Chupradit, Laura Rice, Gil Ju Seo, Guillaume Calmettes, Chandran Ramakrishna and 7 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 234 papers.

0numbers the graph read from it
0cells of the map it votes in
234citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

234 citing papers in PubMed, 348 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Orai1-mediated CaExperimental & molecular medicine · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

174 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Sonal SrikanthDepartment of Physiology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. ssrikanth@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-3034-095X
Jin Seok WooDepartment of Physiology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Beibei WuDepartment of Physiology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Yasser M El-SherbinyNational Institute for Health Research-Leeds Biomedical Research Centre and Leeds Institute of Rheumatic and Musculoskeletal Medicine, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, UK.ORCID http://orcid.org/0000-0003-4791-3475
Jennifer LeungDepartment of Physiology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Koollawat ChupraditDivision of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Laura RiceLeeds Institute of Biomedical and Clinical Sciences, University of Leeds, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, UK.
Gil Ju SeoDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Guillaume CalmettesDepartment of Medicine (Cardiology), David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Chandran RamakrishnaDepartment of Molecular Immunology, City of Hope Beckman Research Institute, Duarte, CA, USA.
Edouard CantinDepartment of Molecular Immunology, City of Hope Beckman Research Institute, Duarte, CA, USA.ORCID http://orcid.org/0000-0002-2352-710X
Dong Sung AnDivision of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Ren SunDepartment of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA.
Ting-Ting WuDepartment of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA.
Jae U JungDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-4559-8774
Sinisa SavicNational Institute for Health Research-Leeds Biomedical Research Centre and Leeds Institute of Rheumatic and Musculoskeletal Medicine, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, UK.ORCID http://orcid.org/0000-0001-7910-0554
Yousang GwackDepartment of Physiology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. ygwack@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-2821-9245
University of California, Los Angeles · USCity of Hope · USUniversity of Southern California · USMansoura University · EGSt James's University Hospital · GBUniversity of Leeds · GB

Funding

Roles of the K3 and K5 in KSHV Persistence and PathogenesisP01CA180779 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2013 to 2017
$7.3M
Molecular Basis of KSHV oncogenesisR35CA200422 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2016 to 2022
$6.1M
Role of viral BCI-2 mediated anti-apoptosis and-autophagyR01AI073099 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2007 to 2017
$4.3M
KSHV Epigenetic RegulationR01DE023926 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2013 to 2024
$4.2M
SFTSV nonstructural protein NSs-mediated immunopathogenesisR01AI140705 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2018 to 2022
$4.2M
Novel regulators of store-operated Ca2+ entry in immune systemsR01AI083432 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GWACK, YOUSANG · 2009 to 2020
$3.8M
TRIM9-mediated anti-viral immune pathwayR01AI116585 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2015 to 2019
$2.3M
Role of autophagy for Zika virus lifecycleR21AI129496 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2017 to 2018
$454k
Regulation of lymphangiogenesis by KSHV vIRF3R21DE027888 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2018 to 2019
$451k
Role of histone demethylase Kdm3C in age-associated oral and systemic inflammationR21DE028269 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GWACK, YOUSANG, KANG, MO K. · 2018 to 2019
$429k
Distinct functions of Orai1 and Orai2 in naive and effector helper T cellsR21AI130653 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SRIKANTH, SONAL · 2017 to 2018
$424k
NCI NIH HHS P01 CA180779NCI NIH HHS R35 CA200422NIAID NIH HHS R01 AI073099NIAID NIH HHS R01 AI083432NIAID NIH HHS R01 AI116585NIAID NIH HHS R01 AI140705NIAID NIH HHS R21 AI129496NIAID NIH HHS R21 AI130653NIDCR NIH HHS R01 DE023926NIDCR NIH HHS R21 DE027888NIDCR NIH HHS R21 DE028269
6 · The paper itself

Abstract

Stimulator of interferon genes (STING) is an endoplasmic reticulum (ER) signaling adaptor that is essential for the type I interferon response to DNA pathogens. Aberrant activation of STING is linked to the pathology of autoimmune and autoinflammatory diseases. The rate-limiting step for the activation of STING is its translocation from the ER to the ER-Golgi intermediate compartment. Here, we found that deficiency in the Ca

Indexed as

AnimalsChild, PreschoolChlorocebus aethiopsDisease Models, AnimalDNA, ViralEndoplasmic ReticulumFibroblastsGene Knockout TechniquesHEK293 CellsHerpes SimplexHerpesvirus 1, HumanHumansImmunity, InnateInterferon Type IJurkat CellsMacrophagesDNA, ViralInterferon Type IMembrane ProteinsNeoplasm ProteinsSTIM1 protein, humanStim1 protein, mouseSTING1 protein, humanSting1 protein, mouseSTING ProteinStromal Interaction Molecule 1

Identifiers

PMID30643259
PMCPMC6340781
OpenAlexW2906051249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.